Metformin eller et farmasøytisk akseptabelt salt derav； saksagliptin eller et farmasøytisk akseptabelt salt derav； dapagliflozin eller et farmasøytisk akseptabelt solvat derav

• 收藏
• 分享

专利权人:

AstraZeneca AB;AstraZeneca UK Limited

发明人:

申请号：

NO2020009

公开号：

NO2020009I1

申请日:

2020.05.04

申请国别(地区):

NO

年份:

2020

代理人:

摘要：

The present invention relates to bilayer tablets comprising a metformin hydrochloride formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention further relates to medical uses of said bilayer tablets and to pharmaceutical combinations comprising said bilayer tablets.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/